← All trials
NCT05288660
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 27, 2014
- Primary completion
- Mar 13, 2015
- Completion date
- Mar 13, 2015
- First posted
- Mar 21, 2022
- Last posted
- Mar 21, 2022
- Enrollment
- 14
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- AlexionLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.